JP2021529527A5 - - Google Patents

Info

Publication number
JP2021529527A5
JP2021529527A5 JP2020573229A JP2020573229A JP2021529527A5 JP 2021529527 A5 JP2021529527 A5 JP 2021529527A5 JP 2020573229 A JP2020573229 A JP 2020573229A JP 2020573229 A JP2020573229 A JP 2020573229A JP 2021529527 A5 JP2021529527 A5 JP 2021529527A5
Authority
JP
Japan
Prior art keywords
medium
concentrated
cells
batch
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020573229A
Other languages
English (en)
Japanese (ja)
Other versions
JP7419273B2 (ja
JP2021529527A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/040298 external-priority patent/WO2020010080A1/en
Publication of JP2021529527A publication Critical patent/JP2021529527A/ja
Publication of JP2021529527A5 publication Critical patent/JP2021529527A5/ja
Priority to JP2024001657A priority Critical patent/JP2024050590A/ja
Application granted granted Critical
Publication of JP7419273B2 publication Critical patent/JP7419273B2/ja
Priority to JP2025247705A priority patent/JP2026048825A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573229A 2018-07-03 2019-07-02 組換えタンパク質を製造する方法 Active JP7419273B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024001657A JP2024050590A (ja) 2018-07-03 2024-01-10 組換えタンパク質を製造する方法
JP2025247705A JP2026048825A (ja) 2018-07-03 2025-12-12 組換えタンパク質を製造する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862693606P 2018-07-03 2018-07-03
US62/693,606 2018-07-03
PCT/US2019/040298 WO2020010080A1 (en) 2018-07-03 2019-07-02 Methods of producing recombinant proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024001657A Division JP2024050590A (ja) 2018-07-03 2024-01-10 組換えタンパク質を製造する方法

Publications (3)

Publication Number Publication Date
JP2021529527A JP2021529527A (ja) 2021-11-04
JP2021529527A5 true JP2021529527A5 (cg-RX-API-DMAC7.html) 2022-07-08
JP7419273B2 JP7419273B2 (ja) 2024-01-22

Family

ID=67470657

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020573229A Active JP7419273B2 (ja) 2018-07-03 2019-07-02 組換えタンパク質を製造する方法
JP2024001657A Pending JP2024050590A (ja) 2018-07-03 2024-01-10 組換えタンパク質を製造する方法
JP2025247705A Pending JP2026048825A (ja) 2018-07-03 2025-12-12 組換えタンパク質を製造する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024001657A Pending JP2024050590A (ja) 2018-07-03 2024-01-10 組換えタンパク質を製造する方法
JP2025247705A Pending JP2026048825A (ja) 2018-07-03 2025-12-12 組換えタンパク質を製造する方法

Country Status (23)

Country Link
US (2) US12624336B2 (cg-RX-API-DMAC7.html)
EP (2) EP4368699A3 (cg-RX-API-DMAC7.html)
JP (3) JP7419273B2 (cg-RX-API-DMAC7.html)
KR (2) KR102870511B1 (cg-RX-API-DMAC7.html)
CN (1) CN112839954A (cg-RX-API-DMAC7.html)
AU (1) AU2019299358B2 (cg-RX-API-DMAC7.html)
CA (1) CA3104684A1 (cg-RX-API-DMAC7.html)
DK (1) DK3818078T3 (cg-RX-API-DMAC7.html)
EA (1) EA202092904A1 (cg-RX-API-DMAC7.html)
ES (1) ES2976708T3 (cg-RX-API-DMAC7.html)
FI (1) FI3818078T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20240584T1 (cg-RX-API-DMAC7.html)
HU (1) HUE066560T2 (cg-RX-API-DMAC7.html)
IL (2) IL279782B2 (cg-RX-API-DMAC7.html)
LT (1) LT3818078T (cg-RX-API-DMAC7.html)
MX (1) MX2020013633A (cg-RX-API-DMAC7.html)
PL (1) PL3818078T3 (cg-RX-API-DMAC7.html)
PT (1) PT3818078T (cg-RX-API-DMAC7.html)
RS (1) RS65472B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202012582QA (cg-RX-API-DMAC7.html)
SI (1) SI3818078T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400173T1 (cg-RX-API-DMAC7.html)
WO (1) WO2020010080A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL279782B2 (en) 2018-07-03 2026-05-01 Bristol Myers Squibb Co Methods for producing recombinant proteins
EP4229174A1 (en) * 2020-10-13 2023-08-23 Boehringer Ingelheim International GmbH Systems and methods for producing a biologic molecule with hydrocyclone cell retention device
DK181991B1 (en) * 2021-11-11 2025-05-15 Dsm Ip Assets Bv Combined fermentation process for producing one or more human milk oligosaccharide(s) (hmo(s)) in escherichia coli
AU2023295808A1 (en) * 2022-06-15 2025-01-30 UCB Biopharma SRL Cell culture processes
EP4339274B1 (en) 2022-09-13 2025-03-26 Sartorius Stedim Biotech GmbH Method for operating a bioprocess installation for production of a bioproduct
KR20240172522A (ko) * 2023-06-01 2024-12-10 (주)알테오젠 지속형 호르몬 수용체 길항제의 생산 방법

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
JP2749167B2 (ja) 1988-06-21 1998-05-13 ジェネンテク,インコーポレイテッド 心筋梗塞の処置のための方法および治療用組成物
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB2251249B (en) 1990-12-28 1995-06-21 Mogam Biotech Res Inst High-density medium for animal cell culture
EP1260521B1 (en) 1991-08-14 2007-11-21 Genentech Inc. Immunoglobulin variants for specific Fc epsilon receptors
CA2140933A1 (en) 1992-08-21 1994-02-22 Paula M. Jardieu Method for treating an lfa-1 mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
EP0733207B1 (en) 1993-12-10 1997-08-27 Genentech, Inc. Methods for diagnosis of allergy and screening of anti-allergy therapeutics
AP660A (en) 1994-01-18 1998-08-18 Genentech Inc A method of treatment of parasitic infection using IgE antagonists.
US5707622A (en) 1994-03-03 1998-01-13 Genentech, Inc. Methods for treating ulcerative colitis
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
CA2222231A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
PT877626E (pt) 1996-01-23 2003-01-31 Univ Vermont And State Agric C Anticorpos anti-cd1s para utilizacao contra icto
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
EP2221361A3 (en) 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
AU731817C (en) 1996-11-27 2001-11-01 Genentech Inc. Humanized anti-CD11a antibodies
DE69829891T2 (de) 1997-04-07 2005-10-06 Genentech, Inc., South San Francisco Anti-VEGF Antikörper
PT981618E (pt) 1997-05-15 2007-11-23 Genentech Inc ''anticorpo anti-apo-2''
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
KR100490077B1 (ko) 1999-10-29 2005-05-17 제넨테크, 인크. 항-전립선 줄기세포 항원 (psca) 항체 조성물 및 그의사용 방법
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
US7335491B2 (en) 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
TW201516149A (zh) 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
MX2009004974A (es) 2006-11-08 2009-05-20 Wyeth Corp Medios diseñado racionalmente para cultivo celular.
WO2009023562A2 (en) 2007-08-09 2009-02-19 Wyeth Use of perfusion to enhance production of fed-batch cell culture in bioreactors
DK2501822T3 (da) 2009-11-17 2017-11-27 Squibb & Sons Llc Fremgangsmåder til forbedret proteinproduktion
LT2673296T (lt) 2011-02-07 2019-02-25 Cerenis Therapeutics Holding Sa Lipoproteino kompleksai ir jų gamyba ir jų panaudojimai
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
SI2726600T1 (sl) * 2011-07-01 2017-07-31 Amgen Inc. Sesalska celična kultura
WO2015095809A1 (en) * 2013-12-20 2015-06-25 Biogen Idec Ma Inc. Use of perfusion seed cultures to improve biopharmaceutical fed-batch production capacity and product quality
MA40021A (fr) * 2014-06-03 2015-12-10 Lupin Ltd Processus de culture cellulaire destiné à produire une protéine
KR102391259B1 (ko) * 2014-06-04 2022-04-26 암젠 인크 포유류 세포 배양물을 회수하는 방법
JP5731726B1 (ja) 2014-06-26 2015-06-10 楽天株式会社 情報処理装置、情報処理方法及び情報処理プログラム
EP3420072B1 (en) 2016-02-22 2025-06-18 Agency for Science, Technology and Research Cell culture medium
EP3440190B1 (en) 2016-04-05 2024-08-28 Pfizer Inc. Cell culture process
WO2018039499A1 (en) 2016-08-24 2018-03-01 Regeneron Pharmaceuticals, Inc. Host cell protein modification
IL279782B2 (en) 2018-07-03 2026-05-01 Bristol Myers Squibb Co Methods for producing recombinant proteins

Similar Documents

Publication Publication Date Title
FI3818078T3 (fi) Menetelmiä rekombinanttiproteiinien tuottamiseksi
CN118086167B (zh) 一种生产l-色氨酸的基因工程菌及其构建方法与应用
RU2009138226A (ru) Способы производства белка с использованием соединений, препятствующих старению
JP7680418B2 (ja) 高密度連続接種の細胞培養方法及びその応用
JP2015521848A5 (cg-RX-API-DMAC7.html)
CN104560882B (zh) 一种降低酸性变体含量的cho细胞培养工艺
CN105441497B (zh) 一种利用微生物发酵和微生物转化偶联生产尸胺的方法
CN108795789A (zh) 一种高产衣康酸解脂耶氏酵母工程菌株及其构建方法、发酵工艺与应用
Meng et al. Enhancement of heterologous protein production in Corynebacterium glutamicum via atmospheric and room temperature plasma mutagenesis and high-throughput screening
CN118879517B (zh) 解脂耶罗维亚酵母Yl590及其应用
CN117050163A (zh) 一种分泌表达重组iii型胶原蛋白的毕赤酵母工程菌及其应用
JP2024163267A5 (cg-RX-API-DMAC7.html)
CN118956632A (zh) 高产2′-岩藻糖基乳糖的重组解脂耶氏酵母菌及其构建方法与应用
CN117736948A (zh) 一种高产l-丙氨酸的大肠杆菌重组菌构建方法及应用
JPWO2023200008A5 (cg-RX-API-DMAC7.html)
CN121737169A (zh) 一种缬氨酸生产菌株及其构建方法与应用
CN107287144A (zh) 一种代谢改造的枯草芽孢杆菌生物转化细胞及其制备方法与应用
CN120399917A (zh) 一株高产3-岩藻糖基乳糖的重组解脂耶氏酵母菌及其构建方法和应用
CN116814519B (zh) 一种利用蔗糖生产肌醇的大肠杆菌工程菌株、及其构建方法和应用
CN120173986A (zh) 一种用于黏着剑菌的ed途径调控基因在维生素b12工业生产的应用
CN118931932A (zh) 一种产生l-缬氨酸的大肠杆菌及其应用
CN119161416B (zh) 一种高效合成四氢嘧啶的基因工程菌及其构建方法
CN116254286B (zh) 氰胺诱导的酿酒酵母工程菌及其构建方法
CN114317535B (zh) 基因缺失cho细胞系及其制备方法及应用
AR129619A1 (es) Métodos de producción de proteínas recombinantes en un biorreactor y/o de aumento del rendimiento del cultivo celular mediante estrategia de alimentación específica